Rxsight Inc
RXST7.885USD
+0.085+1.09%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
320.04MCap. mercado
PérdidaP/E TTM
Más Datos de Rxsight Inc Compañía
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Información de la empresa
Símbolo de cotizaciónRXST
Nombre de la empresaRxsight Inc
Fecha de salida a bolsaJul 30, 2021
Director ejecutivoDr. Ron M. Kurtz, M.D.
Número de empleados498
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 30
Dirección100 Columbia Street
CiudadALISO VIEJO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal92656
Teléfono19495217822
Sitio Webhttps://www.rxsight.com/
Símbolo de cotizaciónRXST
Fecha de salida a bolsaJul 30, 2021
Director ejecutivoDr. Ron M. Kurtz, M.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Desglose de ingresos
FY2024
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
139.93M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: lun., 2 de jun
Actualizado: lun., 2 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
Accionistas
Accionistas
Proporción
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
39.90%
Investment Advisor/Hedge Fund
20.21%
Hedge Fund
19.12%
Venture Capital
9.26%
Research Firm
7.81%
Individual Investor
5.51%
Pension Fund
1.27%
Private Equity
0.57%
Bank and Trust
0.46%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
444
40.56M
99.81%
-3.90M
2025Q1
453
40.49M
99.79%
-7.96M
2024Q4
440
38.96M
96.23%
-5.07M
2024Q3
420
38.15M
94.75%
-3.92M
2024Q2
391
37.00M
93.42%
-2.64M
2024Q1
338
34.63M
93.15%
-2.60M
2023Q4
299
33.17M
91.51%
-284.01K
2023Q3
253
34.41M
96.36%
-1.84M
2023Q2
214
31.39M
90.12%
+2.22M
2023Q1
160
26.47M
84.63%
+4.14M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
RA Capital Management, LP
3.74M
9.21%
--
--
Mar 31, 2025
Millennium Management LLC
897.85K
2.21%
-109.69K
-10.89%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
6.29%
-18.59K
-0.72%
Mar 31, 2025
Divisadero Street Capital Management, LP
2.53M
6.23%
+1.65M
+185.91%
Apr 03, 2025
The Vanguard Group, Inc.
2.38M
5.87%
+8.50K
+0.36%
Mar 31, 2025
BofA Global Research (US)
2.18M
5.37%
+35.62K
+1.66%
Mar 31, 2025
Artisan Partners Limited Partnership
1.77M
4.35%
+215.90K
+13.91%
Mar 31, 2025
Brown Capital Management, LLC
947.29K
2.33%
+105.10K
+12.48%
Mar 31, 2025
State Street Global Advisors (US)
898.67K
2.21%
+7.87K
+0.88%
Mar 31, 2025
Fidelity Management & Research Company LLC
888.74K
2.19%
-41.99K
-4.51%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
Nuveen ESG Small-Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
WisdomTree US SmallCap Fund
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Global X Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
Proporción0.04%
Nuveen ESG Small-Cap ETF
Proporción0.04%
iShares Russell 2000 Growth ETF
Proporción0.03%
iShares Russell 2000 ETF
Proporción0.02%
WisdomTree US SmallCap Fund
Proporción0.02%
ProShares Hedge Replication ETF
Proporción0.02%
ProShares UltraPro Russell2000
Proporción0.02%
Global X Russell 2000 ETF
Proporción0.02%
Proshares Ultra Russell 2000
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
